MPGAX
Price
$11.70
Change
-$0.03 (-0.26%)
Updated
Sep 5 closing price
Net Assets
44.47M
RGEBX
Price
$82.89
Change
+$0.45 (+0.55%)
Updated
Sep 8 closing price
Net Assets
332.38B
Interact to see
Advertisement

MPGAX vs RGEBX

Header iconMPGAX vs RGEBX Comparison
Open Charts MPGAX vs RGEBXBanner chart's image
MassMutual Disciplined Gr A
Price$11.70
Change-$0.03 (-0.26%)
VolumeN/A
Net Assets44.47M
American Funds Growth Fund of Amer R2E
Price$82.89
Change+$0.45 (+0.55%)
VolumeN/A
Net Assets332.38B
MPGAX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MPGAX vs. RGEBX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPGAX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. MPGAX (44.5M). MPGAX (0.00) and RGEBX (0.00) have matching dividends . MPGAX was incepted earlier than RGEBX: MPGAX (21 years) vs RGEBX (11 years). MPGAX (1.09) and RGEBX (1.09) have similar cost to investors . MPGAX is a more actively managed with annual turnover of: 69.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MPGAX: RGEBX (250) vs MPGAX (1000). RGEBX annual gain was more profitable for investors over the last year : 20.12 vs. MPGAX (7.18). RGEBX return over 5 years is better than : 40.41 vs. MPGAX (-8.28).
MPGAXRGEBXMPGAX / RGEBX
Total Expense Ratio1.091.09100%
Annual Report Gross Expense Ratio1.091.09100%
Fund Existence21 years11 years-
Gain YTD12.53915.39881%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets44.5M332B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.1820.1236%
Returns for 3 years48.7249.8398%
Returns for 5 years-8.2840.41-20%
Returns for 10 years3.8791.534%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMAX0.26N/A
+1.15%
Powell Max Ltd
DNLI15.510.08
+0.52%
Denali Therapeutics
FRPH25.580.11
+0.43%
FRP Holdings
CNA47.71-0.30
-0.62%
CNA Financial Corp
ARTV3.11-0.50
-13.85%
Artiva Biotherapeutics Inc